IRIDEX Corporation
IRIX
Rank in Stocks
#28100
IRIDEX Corporation is a medical technology firm specializing in ophthalmology.... IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
Share Price
$0.7062
Last synced: 2026-11-09
Market Cap
$12.40M
Change (1 day)
7.42%
Change (1 year)
-40.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade IRIDEX Corporation (IRIX)
Category
Healthcare
Operating Margin for IRIDEX Corporation (IRIX)
Operating Margin as of November 2026 TTM: -5.39%
According to IRIDEX Corporation's latest financial reports, its current operating margin (TTM) is -5.39%. At the end of 2024 the company had an operating margin of -17.06%.
Operating Margin history for IRIDEX Corporation from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -5.39% | -68.41% |
| 2024 | -17.06% | -11.56% |
| 2023 | -19.29% | 45.69% |
| 2022 | -13.24% | -5.29% |
| 2021 | -13.98% | -22.81% |
| 2020 | -18.11% | -12.34% |
| 2019 | -20.66% | -31.61% |
| 2018 | -30.21% | -2.52% |
| 2017 | -30.99% | 457.37% |
| 2016 | -5.56% | -905.80% |
| 2015 | 0.69% | -88.58% |
| 2014 | 6.04% | -12.21% |
| 2013 | 6.88% | -370.87% |
| 2012 | -2.54% | -143.57% |
| 2011 | 5.83% | -8.91% |
| 2010 | 6.40% | 9.78% |
| 2009 | 5.83% | -137.54% |
| 2008 | -15.53% | -64.24% |
| 2007 | -43.43% | 227.28% |
| 2006 | -13.27% | -371.37% |
| 2005 | 4.89% | -249.09% |
| 2004 | -3.28% | 2,086.67% |
| 2003 | -0.15% | -74.58% |
| 2002 | -0.59% | -91.91% |
| 2001 | -7.29% | -187.41% |
| 2000 | 8.34% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -102.83% |
US
|
|
| 18.08% | -103.35% |
IE
|
|
| 21.25% | -103.94% |
US
|
|
| 21.05% | -103.91% |
US
|
|
| 28.09% | -105.21% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about IRIDEX Corporation's operating margin
What is IRIDEX Corporation's operating margin?
IRIDEX Corporation's operating margin is -5.39%, as of Nov 2026.
What was IRIDEX Corporation's operating margin in 2024?
In 2024, IRIDEX Corporation's operating margin was -17.06%, compared with -19.29% in 2023.
How has IRIDEX Corporation's operating margin changed since 2019?
From 2019 to 2024, IRIDEX Corporation's operating margin was highest in 2022 (-13.24%) and lowest in 2019 (-20.66%).
How does IRIDEX Corporation's operating margin compare with similar companies?
IRIDEX Corporation's operating margin (-5.39%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.